Liz Parrish in keynote interview at The Business of Longevity Conference in Hong Kong

On October 27th 2017  The Economist magazine held a conference on the economic impact of extreme Longevity, bringing together leading minds to discuss how society can make the transition to an older but still productive population.

 

Our CEO, Liz Parrish was invited at this event for a keynote interview with Charles Goddard, the editorial director for The Economist Asia Pacific Intelligence Unit.  They discussed the complexity of regulations, the extraordinarily long time it takes for drug development from bench to bedside, the current funding environment surrounding biotech, and the pace of medical innovations.  During the keynote, Liz emphasized that BioViva’s main aim is to make advanced gene and cell therapies available to all patients in need. To further this cause BioViva supports innovative and adaptive clinical trials, new models for preclinical testing, and accelerating the time to develop advanced gene and cell therapy.  Finally, Liz highlighted the importance  of testing gene and cell therapy in humans as quickly as possible, because animal models are not accurate.  

IMG_20171027_165114.jpg
Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee